학술논문
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Document Type
Article
Author
Long, Georgina V; Dummer, Reinhard; Hamid, Omid; Gajewski, Thomas F; Caglevic, Christian; Dalle, Stephane; Arance, Ana; Carlino, Matteo S; Grob, Jean-Jacques; Kim, Tae Min; Demidov, Lev; Robert, Caroline; Larkin, James; Anderson, James R; Maleski, Janet; Jones, Mark; Diede, Scott J; Mitchell, Tara C
Source
In The Lancet Oncology August 2019 20(8):1083-1097
Subject
Language
ISSN
1470-2045